← Back
Data updated: Jul 17, 2026
ANDRX LABS LLC
Pharma Pharmaceuticals
ANDRX LABS LLC is a pharmaceutical company with 2 FDA-approved products.
2004
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
ANDRX LABS LLC's Key Drugs
ANDRX LABS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
ANDRX LABS LLC's Recent FDA Approvals
New NDA/BLA approvals for ANDRX LABS LLC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
ANDRX LABS LLC's Therapeutic Areas
Disease areas where ANDRX LABS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ANDRX LABS LLC Pipeline Snapshot
Active clinical trials for ANDRX LABS LLC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2004-04-27
- Latest
- 2018-11-08
- Applications
- 2
FDA Sponsor Names
ANDRX LABS LLCANDRX PHARM